Earnings calendar/IDYA
IDEAYA Biosciences, Inc. (IDYA)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 3, 2026
Consensus estimate row
EPS target
$-1.28
Street estimate
Revenue target
$9.9M
Street estimate
Trailing EPS (avg 4Q)
$-0.48
Beat rate last 4: 50%
Latest EPS YoY
-38.6%
vs 2025-08-05
Latest revenue YoY
—
How results look so far
Trailing revenue (avg 4Q)
$58.5M
Printed quarters
EPS beat rate (4Q)
50%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 4, 2026
EPS miss
EPS actual / est
$-1.22 / $-1.06
-15.1%
Revenue actual / est
$8.9M / $8.0M
+10.4%
Result
Below target
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/3/2026upcoming | $-1.28 | Pending | — | $9.9M | Pending | — |
| 8/4/2026 | $-1.06 | $-1.22 | -15.1% | $8.0M | $8.9M | +10.4% |
| 5/11/2026upcoming | $-0.99 | Pending | — | $5.0M | Pending | — |
| 5/5/2026 | $-1.07 | $-1.11 | -3.7% | $5.0M | $6.6M | +30.2% |
| 2/17/2026 | $-0.95 | $-0.94 | +1.2% | $6.3M | $10.9M | +72.5% |
| 2/12/2026upcoming | $-1.03 | Pending | — | — | Pending | — |
| 11/4/2025 | $-0.95 | $1.33 | +240.6% | $5.9M | $207.8M | +3395.1% |
| 8/5/2025 | $-0.85 | $-0.88 | -3.5% | $2.0M | Pending | — |
| 5/6/2025 | $-0.75 | $-0.82 | -9.3% | $2.4M | Pending | — |
| 2/13/2025 | $-0.67 | $-1.49 | -122.4% | $2.5M | $7.0M | +180.6% |
| 11/4/2024 | $-0.67 | $-0.60 | +10.4% | $4.3M | Pending | — |
| 8/6/2024 | $-0.55 | $-0.68 | -23.6% | $4.8M | Pending | — |
| 5/7/2024 | $-0.53 | $-0.53 | 0.0% | $4.5M | Pending | — |
| 2/20/2024 | $-0.49 | $-0.52 | -6.1% | $8.8M | $3.9M | -55.6% |
| 11/7/2023 | $-0.47 | $-0.46 | +2.1% | $7.8M | $8.0M | +2.5% |
| 8/10/2023 | $-0.53 | $-0.50 | +5.7% | $4.5M | $3.5M | -21.4% |
| 5/9/2023 | $-0.51 | $-0.49 | +3.9% | $4.8M | $7.9M | +64.5% |
| 3/7/2023 | $-0.57 | $-0.50 | +12.3% | $7.0M | $4.0M | -42.5% |
| 11/8/2022 | $-0.65 | $0.04 | +106.2% | $6.6M | $29.7M | +347.2% |
| 8/15/2022 | $-0.57 | $-0.57 | 0.0% | $7.7M | $5.9M | -23.9% |
| 5/10/2022 | $-0.41 | $-0.36 | +12.2% | $6.7M | $11.4M | +69.3% |
| 3/15/2022 | $-0.31 | $-0.47 | -51.6% | $9.0M | $3.0M | -67.0% |
| 11/15/2021 | $-0.29 | $-0.31 | -6.9% | $9.0M | $9.0M | -0.0% |
| 8/10/2021 | $-0.07 | $-0.33 | -371.4% | $8.8M | $8.8M | 0.0% |
| 5/10/2021 | $-0.28 | $-0.28 | 0.0% | $7.0M | $7.2M | +3.8% |
| 3/23/2021 | $-0.18 | $-0.18 | 0.0% | — | $10.6M | — |
| 11/12/2020 | $1.34 | $-0.17 | -112.7% | $17.4M | $9.0M | -48.3% |
| 8/12/2020 | $2.24 | $-0.59 | -126.3% | — | Pending | — |
| 5/12/2020 | $-0.57 | $-0.59 | -3.5% | — | Pending | — |
| 3/24/2020 | $-0.57 | $-0.53 | +7.0% | — | Pending | — |
| 11/13/2019 | $-0.67 | $-0.54 | +19.4% | — | Pending | — |
| 8/12/2019 | $-0.64 | $-1.30 | -103.1% | — | Pending | — |
| 5/28/2019 | — | $-0.49 | — | — | Pending | — |
| 5/24/2019 | — | $-0.60 | — | — | Pending | — |
| 9/30/2018 | — | $-0.92 | — | — | Pending | — |
| 6/30/2018 | — | $-0.49 | — | — | Pending | — |
| 3/31/2018 | — | $-0.40 | — | — | Pending | — |
Need IDYA data in your own agent or pipeline?
The earnings data on this page — report dates, consensus EPS/revenue estimates, actuals and surprise history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.